McKesson to Buy Precision Medicine in $2.25 Billion Deal

McKesson (MCK) has agreed to acquire Precision Medicine in a transaction worth roughly $2.25 billion

$MCK $BGHL · 💬 0

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。